Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Although pricing and allocation pose serious challenges to ensuring access to Covid-19 medicines and vaccines globally, as Mike Piccarreta, partner at consulting firm Kearney, notes: “Delivering a vaccine at a truly global scale will present logistical challenges across all steps of the supply chains.” Big Pharma’s commitments to and mechanisms for equitable access are moot if vaccines and drugs, once approved, cannot actually be manufactured at sufficient scale or be delivered to patients across the world.